Oxidative stress in cancer-bearing dogs assessed by measuring serum malondialdehyde

BMC Veterinary Research

Patcharee Boonsiri¹  Roongpet Tangrassameeprasert¹  Ekkachai Pattarapanwichien³  Komgrit Pimpakdee⁴  Peerapol Sukon²  Fanan Suksawat⁵  Arayaporn Macotpet⁵ 

[1] Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen, 40002, Thailand;Department of Anatomy, Faculty of Veterinary Medicine, Khon Kaen University, Khon Kaen, 40002, Thailand;Department of Pathobiology, Faculty of Veterinary Medicine, Khon Kaen University, Khon Kaen, 40002, Thailand;Department of Public Health, Faculty of Veterinary Medicine, Khon Kaen University, Khon Kaen, 40002, Thailand;Department of Medicine, Faculty of Veterinary Medicine, Khon Kaen University, Khon Kaen, 40002, Thailand

关键词: Dog;    Cancer;    Malondialdehyde;    Oxidative stress;   

Others  :  1119537
DOI  :  10.1186/1746-6148-9-101

 received in 2013-01-25, accepted in 2013-05-04,  发布年份 2013

【 摘 要 】

Background

Oxidative stress, an excess of reactive oxygen species (ROS), causes lipid peroxidation resulting in cell and tissue damages. It may be associated with the development and progression of cancers in dogs. Malondialdehyde (MDA), the end product of lipid peroxidation, is commonly used as a marker of oxidative stress. The objective of this study was to assess oxidative stress in cancer-bearing dogs by measuring serum MDA levels. All client-owned dogs underwent physical examination at the Veterinary Teaching Hospital, Faculty of Veterinary Medicine, Khon Kaen University to determine the health status with the owner’s consent. Blood samples of cancer-bearing dogs (N = 80) and clinically normal dogs (N = 101) were obtained and subjected for determination of MDA levels. In addition, complete blood count, creatinine, and alanine aminotransferase were measured.

Results

Serum MDA was significantly higher in cancer-bearing dogs than in clinically normal dogs (mean ± SD, 4.68 ± 1.32 μmol/L vs 2.95 ± 0.61 μmol/L, respectively; p < 0.001). Packed cell volume (mean ± SD, 36.18 ± 7.65% vs 44.84 ± 5.54%), hemoglobin (mean ± SD, 11.93 ± 2.88 g% vs 15.17 ± 2.00 g%) and red blood cells (median (IQA), 6.05 (2.15) vs 8.09 (1.34)) were all significantly lower in cancer-bearing dogs than in clinically normal dogs. However, the reverse was true for white blood cells (median (IQA), 18.20 (11.95) vs 14.90 (5.10)). Neither creatinine nor alanine aminotransferase levels were significantly different between groups.

Conclusions

This study supports the conclusion that oxidative stress is associated with many types of cancers in dogs, as serum MDA levels were significantly higher in cancer-bearing dogs compared to clinically normal dogs.

【 授权许可】

   
2013 Macotpet et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]McMichael MA: Oxidative stress, antioxidants, and assessment of oxidative stress in dogs and cats. J Am Vet Med Assoc 2007, 231(5):714-720.
• [2]Khanna S, Pande D, Negi R, Karki K, Khanna RS, Khanna HD: Oxidative stress induced damage in benign and malignant breast diseases: histopathological and biochemical aspects. J Stress Physiol Biochem 2012, 8:210-214.
• [3]Hermans N, Cos P, Maes L, De Bruyne T, Vanden Berghe D, Vlietinck AJ, Pieters L: Challenges and pitfalls in antioxidant research. Curr Med Chem 2007, 14(4):417-430.
• [4]Cutler RG: Human longevity and aging: possible role of reactive oxygen species. Ann N Y Acad Sci 1991, 621:1-28.
• [5]Frenkel K: Carcinogen-mediated oxidant formation and oxidative DNA damage. Pharmacol Ther 1992, 53(1):127-166.
• [6]Halliwell B: Antioxidants and human disease: a general introduction. Nutr Rev 1997, 55(1 Pt 2):S44-S49.
• [7]Sharifi N: Commentary: Antioxidants for cancer: new tricks for an old dog? Oncologist 2009, 14(3):213-215.
• [8]Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M: Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006, 160(1):1-40.
• [9]Halliwell B: Oxidative stress and cancer: have we moved forward? Biochem J 2007, 401(1):1-11.
• [10]Klaunig JE, Xu Y, Isenberg JS, Bachowski S, Kolaja KL, Jiang J, Stevenson DE, Walborg EF Jr: The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect 1998, 106(Suppl 1):289-295.
• [11]Hristozov D, Gadjeva V, Vlaykova T, Dimitrov G: Evaluation of oxidative stress in patients with cancer. Arch Physiol Biochem 2001, 109(4):331-336.
• [12]Mauldin G: Nutritional management of the cancer patient. 4th edition. Missouri: Saunders; 2007.
• [13]Sanchez-Perez Y, Carrasco-Legleu C, Garcia-Cuellar C, Perez-Carreon J, Hernandez-Garcia S, Salcido-Neyoy M, Aleman-Lazarini L, Villa-Trevino S: Oxidative stress in carcinogenesis. Correlation between lipid peroxidation and induction of preneoplastic lesions in rat hepatocarcinogenesis. Cancer Lett 2005, 217(1):25-32.
• [14]O’Connell JF, Klein-Szanto AJ, DiGiovanni DM, Fries JW, Slaga TJ: Enhanced malignant progression of mouse skin tumors by the free-radical generator benzoyl peroxide. Cancer Res 1986, 46(6):2863-2865.
• [15]Winter JL, Barber LG, Freeman L, Griessmayr PC, Milbury PE, Blumberg JB: Antioxidant status and biomarkers of oxidative stress in dogs with lymphoma. J Vet Intern Med 2009, 23(2):311-316.
• [16]Bonnett BN, Egenvall A, Olson P, Hedhammar A: Mortality in insured Swedish dogs: rates and causes of death in various breeds. Vet Rec 1997, 141(2):40-44.
• [17]Michell AR: Longevity of British breeds of dog and its relationships with sex, size, cardiovascular variables and disease. Vet Rec 1999, 145(22):625-629.
• [18]Mueller F, Fuchs B, Kaser-Hotz B: Comparative biology of human and canine osteosarcoma. Anticancer Res 2007, 27(1A):155-164.
• [19]Lee R, Margaritis M, Channon KM, Antoniades C: Evaluating oxidative stress in human cardiovascular disease: methodological aspects and considerations. Curr Med Chem 2012, 19(16):2504-2520.
• [20]Kumaraguruparan R, Balachandran C, Manohar BM, Nagini S: Altered oxidant-antioxidant profile in canine mammary tumours. Vet Res Commun 2005, 29(4):287-296.
• [21]Szczubial M, Kankofer M, Lopuszynski W, Dabrowski R, Lipko J: Oxidative stress parameters in bitches with mammary gland tumours. J Vet Med A Physiol Pathol Clin Med 2004, 51(7–8):336-340.
• [22]Gonenc A, Ozkan Y, Torun M, Simsek B: Plasma malondialdehyde (MDA) levels in breast and lung cancer patients. J Clin Pharm Ther 2001, 26(2):141-144.
• [23]do Val Carneiro JL, Nixdorf SL, Mantovani MS, da Silva do Amaral Herrera AC, Aoki MN, Amarante MK, Fabris BA, Pelegrinelli Fungaro MH, Ehara Watanabe MA: Plasma malondialdehyde levels and CXCR4 expression in peripheral blood cells of breast cancer patients. J Cancer Res Clin Oncol 2009, 135(8):997-1004.
• [24]Chole RH, Patil RN, Basak A, Palandurkar K, Bhowate R: Estimation of serum malondialdehyde in oral cancer and precancer and its association with healthy individuals, gender, alcohol, and tobacco abuse. J Cancer Res Ther 2010, 6(4):487-491.
• [25]Peddireddy V, Siva Prasad B, Gundimeda SD, Penagaluru PR, Mundluru HP: Assessment of 8-oxo-7, 8-dihydro-2′-deoxyguanosine and malondialdehyde levels as oxidative stress markers and antioxidant status in non-small cell lung cancer. Biomarkers 2012, 17(3):261-268.
• [26]Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P: Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem 1997, 43(7):1209-1214.
• [27]Wong SH, Knight JA, Hopfer SM, Zaharia O, Leach CN Jr, Sunderman FW Jr: Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem 1987, 33(2 Pt 1):214-220.
• [28]Thrall MA, Weiser G, Allison RW, Campbell : Veterinary Hematology and Clinical Chemistry. 2nd ed. Wiley-Blackwell: Iowa; 2012.
• [29]Pande D, Negi R, Karki K, Khanna S, Khanna RS, Khanna HD: Oxidative damage markers as possible discriminatory biomarkers in breast carcinoma. Transl Res 2012, 160(6):411-418.
• [30]Tug T, Karatas F, Terzi SM, Ozdemir N: Comparison of serum malondialdehyde levels determined by two different methods in patients with COPD: HPLC or TBARS methods. Lab Med 2005, 36(1):41-44.
• [31]Buranakarl C, Trisiriroj M, Pondeenana S, Tungjitpeanpong T, Jarutakanon P, Penchome R: Relationships between oxidative stress markers and red blood cell characteristics in renal azotemic dogs. Res Vet Sci 2009, 86(2):309-313.
• [32]Franca RT, Da Silva AS, Costa MM, Paim FC, Paim CB, Thome GR, Wolkmer P, Pereira ME, Schetinger MR, Moresco RN: Relationship between oxidative stress and clinical-pathological aspects in dogs experimentally infected with Rangelia vitalii. Res Vet Sci 2012, 93(3):1309-1313.
• [33]Meydani M: Vitamin E. Lancet 1995, 345(8943):170-175.
• [34]Karihtala P, Soini Y: Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. APMIS 2007, 115(2):81-103.
• [35]Kong Q, Beel JA, Lillehei KO: A threshold concept for cancer therapy. Med Hypotheses 2000, 55(1):29-35.
• [36]Datta K, Sinha S, Chattopadhyay P: Reactive oxygen species in health and disease. Natl Med J India 2000, 13(6):304-310.
• [37]Langseth L: Oxidants, Antioxidants, and Disease Prevention. Washington DC: ILSI Press; 1995.
• [38]Finora K: Common paraneoplastic syndromes. Clin Tech Small Anim Pract 2003, 18(2):123-126.
• [39]Madewell BR, Feldman BF: Characterization of anemias associated with neoplasia in small animals. J Am Vet Med Assoc 1980, 176(5):419-425.
• [40]Mellanby R: Paraneoplastic syndromes. 3rd edition. Gloucester: BSAVA; 2011.
• [41]Machlin LJ, Bendich A: Free radical tissue damage: protective role of antioxidant nutrients. FASEB J 1987, 1(6):441-445.
• [42]Grivennikov SI, Greten FR, Karin M: Immunity, inflammation, and cancer. Cell 2010, 140(6):883-899.
• [43]Speca M, Carlson LE, Goodey E, Angen M: A randomized, wait-list controlled clinical trial: the effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med 2000, 62(5):613-622.
• [44]Kasuga I, Makino S, Kiyokawa H, Katoh H, Ebihara Y, Ohyashiki K: Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma. Cancer 2001, 92(9):2399-2405.